Detalhe da pesquisa
1.
PALB2 mutations and prostate cancer risk and survival.
Br J Cancer
; 125(4): 569-575, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34006922
2.
Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland.
Int J Cancer
; 147(10): 2793-2800, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32875559
3.
The spectrum of mutations predisposing to familial breast cancer in Poland.
Int J Cancer
; 145(12): 3311-3320, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173646
4.
Inherited variants in XRCC2 and the risk of breast cancer.
Breast Cancer Res Treat
; 178(3): 657-663, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31463769
5.
Allelic modification of breast cancer risk in women with an NBN mutation.
Breast Cancer Res Treat
; 178(2): 427-431, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31410679
6.
Common Variant in ALDH2 Modifies the Risk of Breast Cancer Among Carriers of the p.K3326* Variant in BRCA2.
JCO Precis Oncol
; 6: e2100450, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35442721
7.
Inherited NBN Mutations and Prostate Cancer Risk and Survival.
Cancer Res Treat
; 51(3): 1180-1187, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30590007
8.
Inherited Variants in BLM and the Risk and Clinical Characteristics of Breast Cancer.
Cancers (Basel)
; 11(10)2019 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31614901
9.
The 30 kb deletion in the APOBEC3 cluster decreases APOBEC3A and APOBEC3B expression and creates a transcriptionally active hybrid gene but does not associate with breast cancer in the European population.
Oncotarget
; 8(44): 76357-76374, 2017 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29100317